{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-062913","form_type":"8-K","ticker":"RKDA","cik":"0001469443","company_name":"Arcadia Biosciences, Inc.","filed_at":"2025-05-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.393360+00:00","generated_at":"2026-05-22T22:31:23.198918+00:00","sec_items":["1.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Arcadia Biosciences amends merger with Roosevelt: extends deadline, revises share formula","bullets":["Termination date extended from May 15, 2025 to August 15, 2025.","Exchange shares fixed at 90% of post-closing outstanding (floor of 80%); prior cash adjustments removed.","Eliminated definitions for Cash Amount, Surplus Amount, Deficit Amount, and Trading Price.","Closing condition amended to require tax-free exchange under Section 351(a) of the Code."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-062913","json":"https://secwatch.observer/filing/0000950170-25-062913.json","markdown":"https://secwatch.observer/filing/0000950170-25-062913.md","text":"https://secwatch.observer/filing/0000950170-25-062913.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1469443/000095017025062913/0000950170-25-062913-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1469443/000095017025062913/rkda-20250430.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T22:31:23.198918+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}